IBANDRONAT Spirig HC sol inj 3 mg/3ml ser pré 3 ml

7680654760012 CH-65476 M05BA06 07.99.0.

Reimbursement limitations:

BONVIVA

Pour le traitement de l'ostéoporose documentée.

IBANDRONAT Spirig HC sol inj 3 mg/3ml ser pré 3 ml
IBANDRONAT Spirig HC sol inj 3 mg/3ml ser pré 3 ml
IBANDRONAT Spirig HC sol inj 3 mg/3ml ser pré 3 ml
1 / 3
google

Details

Product number
6547601
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
acidum ibandronicum 3 mg ut natrii ibandronas monohydricus 3.375 mg, acidum aceticum glaciale, natrii acetas trihydricus, natrii chloridum, natrii hydroxidum, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium 10.63 mg.

Articles (1)

Ibandronat Spirig HC i.v. 3 mg/3 ml, Injektionslösung
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
21/03/2024
Professional SmPC
Français
21/03/2024
Professional SmPC
Italien
21/03/2024

Detailed composition

Substance Quantity Type Category
(N/A)
3.0 MG Substance Wirkstoff (Principe actif)
(N/A)
3.375 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
10.63 MG Substance HBESI

Reimbursement information

Public price
CHF 64.35
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2015

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
65476
Drug name
Ibandronat Spirig HC i.v., Injektionslösung
Galenic form
LSPA
ATC Code
M05BA06
Authorization status
Z
Dispensation category
B
First authorization
28/01/2015
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Packaging details

Description (FR)
IBANDRONAT Spirig HC sol inj 3 mg/3ml ser pré 3 ml
Description (DE)
IBANDRONAT Spirig HC Inj Lös 3 mg/3ml Fertspr 3 ml
Market launch
28/01/2015
Narcotic (BTM)
No

Original drug

Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
CHF 210.75
View original